Hungary has tweaked windfall taxes for key sectors of its economy, increasing the burden further on large retailers while cutting the extraordinary tax payable by drug producers.
New Mexico has agreed to join a proposed nationwide settlement worth up to $21 billion resolving claims that the three largest U.S. drug distributors fueled a deadly opioid epidemic, the state's attorney general said on Tuesday.
South Africa's Aspen Pharmacare is aiming to ramp up its COVID-19 vaccine manufacturing capacity to 1.3 billion doses a year by February 2024, up from a current annual output of around 250 million doses, the company's CEO told Reuters on Monday.
The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.